Botulinum toxin type A 100unit powder for solution for injection vials
NHS hospitals in England used £24,871,162 of indicative cost of Botulinum toxin type A 100unit powder for solution for injection vials in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 6.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Botulinum toxin type A 100unit powder for solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Botulinum toxin type A 100unit powder for solution for injection vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Sheffield Teaching Hospitals Nhs Trust | £1,446,275 |
| University College London Foundation Tr | £1,251,341 |
| University Hpls North Midlands Nhs Trust | £836,805 |
| Northumberland Tyne And Wear Nhs Trust | £797,904 |
| Nottingham University Hospitals Trust | £650,590 |
| Salford Royal Nhs Foundation Trust | £617,562 |
| South Tyneside And Sunderland Nhs Ft | £545,414 |
| Manchester University Nhs Ft | £515,811 |
| Univ Hpl B/Ham Nhs Foundation Trust | £476,246 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £459,693 |
The primary-care picture
Botulinum toxin type A is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Botulinum toxin type A medicine page.